Protein kinase C and calcium distribution in vascular smooth muscle cells from spontaneously hypertensive rats. 1993

M Neusser, and M Tepel, and P Golinski, and Z Zhu, and K H Rahn, and C Spieker, and W Zidek
Medizinische Universitäts-Poliklinik, University of Münster, Germany.

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D007546 Isoquinolines A group of compounds with the heterocyclic ring structure of benzo(c)pyridine. The ring structure is characteristic of the group of opium alkaloids such as papaverine. (From Stedman, 25th ed)
D009131 Muscle, Smooth, Vascular The nonstriated involuntary muscle tissue of blood vessels. Vascular Smooth Muscle,Muscle, Vascular Smooth,Muscles, Vascular Smooth,Smooth Muscle, Vascular,Smooth Muscles, Vascular,Vascular Smooth Muscles
D010879 Piperazines Compounds that are derived from PIPERAZINE.
D011493 Protein Kinase C An serine-threonine protein kinase that requires the presence of physiological concentrations of CALCIUM and membrane PHOSPHOLIPIDS. The additional presence of DIACYLGLYCEROLS markedly increases its sensitivity to both calcium and phospholipids. The sensitivity of the enzyme can also be increased by PHORBOL ESTERS and it is believed that protein kinase C is the receptor protein of tumor-promoting phorbol esters. Calcium Phospholipid-Dependent Protein Kinase,Calcium-Activated Phospholipid-Dependent Kinase,PKC Serine-Threonine Kinase,Phospholipid-Sensitive Calcium-Dependent Protein Kinase,Protein Kinase M,Calcium Activated Phospholipid Dependent Kinase,Calcium Phospholipid Dependent Protein Kinase,PKC Serine Threonine Kinase,Phospholipid Sensitive Calcium Dependent Protein Kinase,Phospholipid-Dependent Kinase, Calcium-Activated,Serine-Threonine Kinase, PKC
D011918 Rats, Inbred SHR A strain of Rattus norvegicus with elevated blood pressure used as a model for studying hypertension and stroke. Rats, Spontaneously Hypertensive,Rats, SHR,Inbred SHR Rat,Inbred SHR Rats,Rat, Inbred SHR,Rat, SHR,Rat, Spontaneously Hypertensive,SHR Rat,SHR Rat, Inbred,SHR Rats,SHR Rats, Inbred,Spontaneously Hypertensive Rat,Spontaneously Hypertensive Rats
D011921 Rats, Inbred WKY A strain of Rattus norvegicus used as a normotensive control for the spontaneous hypertensive rats (SHR). Rats, Wistar Kyoto,Wistar Kyoto Rat,Rats, WKY,Inbred WKY Rat,Inbred WKY Rats,Kyoto Rat, Wistar,Rat, Inbred WKY,Rat, WKY,Rat, Wistar Kyoto,WKY Rat,WKY Rat, Inbred,WKY Rats,WKY Rats, Inbred,Wistar Kyoto Rats
D002118 Calcium A basic element found in nearly all tissues. It is a member of the alkaline earth family of metals with the atomic symbol Ca, atomic number 20, and atomic weight 40. Calcium is the most abundant mineral in the body and combines with phosphorus to form calcium phosphate in the bones and teeth. It is essential for the normal functioning of nerves and muscles and plays a role in blood coagulation (as factor IV) and in many enzymatic processes. Coagulation Factor IV,Factor IV,Blood Coagulation Factor IV,Calcium-40,Calcium 40,Factor IV, Coagulation
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D003600 Cytosol Intracellular fluid from the cytoplasm after removal of ORGANELLES and other insoluble cytoplasmic components. Cytosols

Related Publications

M Neusser, and M Tepel, and P Golinski, and Z Zhu, and K H Rahn, and C Spieker, and W Zidek
July 2002, Clinical and experimental pharmacology & physiology,
M Neusser, and M Tepel, and P Golinski, and Z Zhu, and K H Rahn, and C Spieker, and W Zidek
September 1992, Japanese heart journal,
M Neusser, and M Tepel, and P Golinski, and Z Zhu, and K H Rahn, and C Spieker, and W Zidek
April 1990, Journal of hypertension,
M Neusser, and M Tepel, and P Golinski, and Z Zhu, and K H Rahn, and C Spieker, and W Zidek
February 1992, Journal of hypertension,
M Neusser, and M Tepel, and P Golinski, and Z Zhu, and K H Rahn, and C Spieker, and W Zidek
December 1993, Journal of hypertension. Supplement : official journal of the International Society of Hypertension,
M Neusser, and M Tepel, and P Golinski, and Z Zhu, and K H Rahn, and C Spieker, and W Zidek
August 1985, Life sciences,
M Neusser, and M Tepel, and P Golinski, and Z Zhu, and K H Rahn, and C Spieker, and W Zidek
October 2003, Clinical and experimental hypertension (New York, N.Y. : 1993),
M Neusser, and M Tepel, and P Golinski, and Z Zhu, and K H Rahn, and C Spieker, and W Zidek
January 1984, Journal of cardiovascular pharmacology,
M Neusser, and M Tepel, and P Golinski, and Z Zhu, and K H Rahn, and C Spieker, and W Zidek
January 1983, Clinical and experimental hypertension. Part A, Theory and practice,
M Neusser, and M Tepel, and P Golinski, and Z Zhu, and K H Rahn, and C Spieker, and W Zidek
March 1992, Clinical and experimental pharmacology & physiology,
Copied contents to your clipboard!